These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 29098626)

  • 1. MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
    Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J
    Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes Mediate the Beneficial Effects of Exercise.
    Li Y; Han C; Wang J; Zhou J; Liang C; Ranganna K; Song YH
    Adv Exp Med Biol; 2017; 1000():333-353. PubMed ID: 29098629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs in response to exercise.
    Xu T; Liu Q; Yao J; Dai Y; Wang H; Xiao J
    Scand J Med Sci Sports; 2015 Apr; 25(2):e149-54. PubMed ID: 25648616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in heart and circulation during physical exercise.
    Wang L; Lv Y; Li G; Xiao J
    J Sport Health Sci; 2018 Oct; 7(4):433-441. PubMed ID: 30450252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-222 in Cardiovascular Diseases: Physiology and Pathology.
    Ding S; Huang H; Xu Y; Zhu H; Zhong C
    Biomed Res Int; 2017; 2017():4962426. PubMed ID: 28127557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise, Skeletal Muscle and Circulating microRNAs.
    Russell AP; Lamon S
    Prog Mol Biol Transl Sci; 2015; 135():471-96. PubMed ID: 26477927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker.
    Huang Y; Li J
    J Physiol Biochem; 2015 Sep; 71(3):479-86. PubMed ID: 25840809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
    Wang F; Chen C; Wang D
    Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise for the heart: signaling pathways.
    Tao L; Bei Y; Zhang H; Xiao J; Li X
    Oncotarget; 2015 Aug; 6(25):20773-84. PubMed ID: 26318584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNAs in cardiovascular disease.
    Papageorgiou N; Tousoulis D; Androulakis E; Siasos G; Briasoulis A; Vogiatzi G; Kampoli AM; Tsiamis E; Tentolouris C; Stefanadis C
    Curr Med Chem; 2012; 19(16):2605-10. PubMed ID: 22489721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA Profile and Adaptive Response to Exercise Training: A Review.
    Domańska-Senderowska D; Laguette MN; Jegier A; Cięszczyk P; September AV; Brzeziańska-Lasota E
    Int J Sports Med; 2019 Apr; 40(4):227-235. PubMed ID: 30791082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of microRNAs in pressure overload- and ischemia-related myocardial remodeling.
    Zhou S; Liu Y; Prater K; Zheng Y; Cai L
    Life Sci; 2013 Nov; 93(23):855-62. PubMed ID: 24021888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
    de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA: A new therapeutic strategy for cardiovascular diseases.
    Samanta S; Balasubramanian S; Rajasingh S; Patel U; Dhanasekaran A; Dawn B; Rajasingh J
    Trends Cardiovasc Med; 2016 Jul; 26(5):407-19. PubMed ID: 27013138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of miR-214 in cardiovascular diseases.
    Zhao Y; Ponnusamy M; Zhang L; Zhang Y; Liu C; Yu W; Wang K; Li P
    Eur J Pharmacol; 2017 Dec; 816():138-145. PubMed ID: 28842125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA in cardiovascular biology and disease.
    Wojciechowska A; Braniewska A; Kozar-Kamińska K
    Adv Clin Exp Med; 2017 Aug; 26(5):865-874. PubMed ID: 29068585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.